Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The macrophage mannose receptor (MR), also known as CD206 or MRC1, is a type I transmembrane glycoprotein and a member of the C-type lectin family. It is predominantly expressed on most tissue macrophages, dendritic cells, and certain lymphatic or endothelial cells. It plays a central role in innate immunity through its role in pathogen recognition and endocytic clearance mechanisms, and also serves as a biomarker/target for imaging inflammatory diseases/tumors due to its selective expression profile on alternatively activated macrophages.
Selective activation of CD206 on M2-polarized macrophages to enhance phagocytosis/autophagy/apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage Mannose Receptor (CD206).